Literature DB >> 21853247

Markers of uremia and pericardial effusion in peritoneal dialysis.

Aline de Araujo Antunes1, Jacqueline Costa Teixeira Caramori, Francieli Delatim Vannini, Silméia Garcia Zanati, Pasqual Barretti, Beatriz Bojikian Matsubara, Roberto Jorge da Silva Franco, Luis Cuadrado Martin.   

Abstract

BACKGROUND: Inadequate dialysis causes accumulation of toxic residues that may lead to the development of dialysis-associated pericardial effusion, but several other factors could be associated with this abnormality. The purpose of this study was to evaluate clinical risk factors to asymptomatic pericardial effusion in peritoneal dialysis.
METHODS: This cross-sectional study included 34 patients aged ≥ 18 years on peritoneal dialysis for at least 3 months, who showed no symptomatic pericardial effusion, hepatic cirrhosis, neoplasias, lupus or amputations, none in minoxidil use. Asymptomatic pericardial effusion was diagnosed by echocardiography. Risk factors were evaluated by logistic regression and Roc curve. Significance level was set at P < 0.05.
RESULTS: Patient age was 51 ± 15.9 years. Of the 34 patients enrolled, 16 were men and 11 diabetic. Five of them presented pericardial effusion. Logistic regression identifies low hemoglobin level (RR 0.454 CI 95%: 0.225-0.913; P = 0.027), low phase angle (RR 0.236 CI 95%: 0.057-0.984; P = 0.048) and low Kt/V (RR 0.001 CI 95%: 0.0-0.492; P = 0.03) as risk factors to pericardial effusion. Roc curve showed that hemoglobin levels below 12.2 g/dL, Kt/V lower than 1.9 and phase angle lower than 4.5° were the best cutoffs to predict pericardial effusion. Four patients showed these three parameters in the unfavorable range, and all these four patients presented pericardial effusion. The other patient with pericardial effusion had two of these parameters reduced.
CONCLUSIONS: These findings corroborate the hypothesis that uremia plays a significant role in the pathogenesis of dialysis-associated pericardial effusion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21853247     DOI: 10.1007/s11255-011-0049-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000.

Authors: 
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  EDITORIAL: The case for a specific uraemic myocardopathy.

Authors:  D Prosser; V Parsons
Journal:  Nephron       Date:  1975       Impact factor: 2.847

3.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

4.  Uremic pericarditis. Clinical features and management.

Authors:  G L Bailey; C L Hampers; E B Hager; J P Merrill
Journal:  Circulation       Date:  1968-09       Impact factor: 29.690

5.  Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition.

Authors:  D Shemin; A G Bostom; C Lambert; C Hill; J Kitsen; A S Kliger
Journal:  Perit Dial Int       Date:  2000 Jul-Aug       Impact factor: 1.756

6.  Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.

Authors:  Ramón Paniagua; Dante Amato; Edward Vonesh; Ricardo Correa-Rotter; Alfonso Ramos; John Moran; Salim Mujais
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

7.  Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study.

Authors:  Wai-Kei Lo; Yiu-Wing Ho; Chun-Sang Li; Kin-Shing Wong; Tak-Mao Chan; Alex Wai-Yin Yu; Flora So-King Ng; Ignatius Kum-Po Cheng
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

8.  Predicting success of intensive dialysis in the treatment of uremic pericarditis.

Authors:  N L De Pace; P F Nestico; A B Schwartz; G S Mintz; J S Schwartz; M N Kotler; C Swartz
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

Review 9.  Pericardial involvement in end-stage renal disease.

Authors:  Martin A Alpert; Mark D Ravenscraft
Journal:  Am J Med Sci       Date:  2003-04       Impact factor: 2.378

10.  Treatment of uremic pericarditis and pericardial effusion.

Authors:  E A Rutsky; S G Rostand
Journal:  Am J Kidney Dis       Date:  1987-07       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.